Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2015 / Cilt: 23 - Sayı: 2

Sıçan aort halkasında dobutamin ve levosimendanın vazorelaksan etkileri

Vasorelaxant effects of dobutamine and levosimendan on rat aorta rings

Pages
330–335
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The pD2 value was found to be 5.2±0.4 forlevosimendan and 4.3±0.2 for dobutamine.Conclusion:­ Levosimendan and dobutamine moleculesin vitro rat aortic rings have similar vasorelaxant effects.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background:­ In this experimental study, the vasorelaxanteffects of levosimendan and dobutamine on isolated ratthoracic aorta preparations were compared.Methods: Sixteen Wistar albino type male rats were used.
📊
Key Findings & Data:Aortic rings ofapproximately 5 mm in length were prepared and placed inthe organ bath.
💡
Conclusion & Impact:The pD2 value was found to be 5.2±0.4 forlevosimendan and 4.3±0.2 for dobutamine.Conclusion:­ Levosimendan and dobutamine moleculesin vitro rat aortic rings have similar vasorelaxant effects.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background:­ In this experimental study, the vasorelaxanteffects of levosimendan and dobutamine on isolated ratthoracic aorta preparations were compared.Methods: Sixteen Wistar albino type male rats were used. Thethoracic aortas were removed carefully and were transferredto petri dishes containing Krebs solution. Aortic rings ofapproximately 5 mm in length were prepared and placed inthe organ bath. Contraction and relaxation forces of the aorticrings were recorded. Contraction response was obtained byapplying 10 -5M phenylephrine to aortic rings. Subsequently,cumulative doses of levosimendan (10 -8M-10 -4M) was appliedto eight aortic rings and cumulative doses of dobutamine(10 -8M-10 -3M) was applied to the other eight aortic ringsand dose-response curves were recorded. The EC 50 and pD2values were calculated by the computer program named GraphPad Prisim 4.0. The Mann-Whitney U-test was performed forstatistical analysis.Results:­ The relaxation response of the aortic rings withlevosimendan 10 -4M administration was %92.33 while therelaxation response with dobutamine 10 -4M administrationwas %82.48. It did not show a significant difference betweenboth relaxation responses (p=0.059). The EC50 value wascalculated as 6.605x10 -6M for dobutamine and 5.093x10 -5Mfor levosimendan. The pD2 value was found to be 5.2±0.4 forlevosimendan and 4.3±0.2 for dobutamine.Conclusion:­ Levosimendan and dobutamine moleculesin vitro rat aortic rings have similar vasorelaxant effects.

Özet

Amaç: Bu deneysel çalışmada, izole sıçan torasik aortpreparatlarında levosimendan ve dobutaminin vazorelaksanetkileri karşılaştırıldı.Ça­lış­ma­pla­nı:­ Çalışmada 16 adet Wistar albino cinsierkek sıçan kullanıldı. Sıçanların torasik aortu dikkatliceçıkarıldı ve Krebs solüsyonu içeren petri kaplarınakonuldu. Aort halkaları 5 mm uzunluğunda olacakşekilde hazırlandı ve organ banyosuna yerleştirildi. Aorthalkalarının kasılma ve gevşeme kuvvetleri kaydedildi.Aort halkalarına 10 -5M fenilefrin uygulanarak kasılmayanıtı elde edildi. Ardından sekiz aort halkasına artandozlarda levosimendan (10 -8M-10 -4M), diğer sekiz aorthalkasına ise yine artan dozlarda dobutamin (10 -8M-10 -3M)uygulanarak doz-yanıt eğrileri kayıt edildi. Graph PadPrisim 4.0 bilgisayar programı ile EC 50 ve pD2 değerlerihesaplandı. İstatistiksel analiz Mann-Whitney U testi ileyapıldı.Bul gu lar: 10 -4M levosimendan uygulaması ile aorthalkalarında %92.33 gevşeme yanıtı, 10 -4M dobutaminuygulaması ile %82.48 gevşeme yanıtı elde edildi. Her ikigevşeme yanıtı arasında anlamlı bir farklılık bulunmadı(p=0.059). EC50 değeri, levosimendan için 6.605x10 -6M,dobutamin için 5.093x10 -5 M olarak hesaplandı. pD2değeri levosimendan için 5.2±0.4, dobutamin için 4.3±0.2bulundu.So­nuç:­ Levosimendan ve dobutamin molekülleri in vitrosıçan aort halkalarında benzer vazorelaksan etkiye sahiptir.

🔖

Cite This Article

PEKER, R. O., DÖNMEZ, S., GÖKALP, O., DOĞAN, E., YENER, A. Ü. (2022). Sıçan aort halkasında dobutamin ve levosimendanın vazorelaksan etkileri. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 23 - Sayı: 2, 330–335. https://ajindex.com/articles/624568

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Montes FR, Echeverri D, Buitrago L, Ramírez I, Giraldo JC, Maldonado JD, et al. The vasodilatory effects of levosimendan on the human internal mammary artery. Anesth Analg 2006;103:1094-8
  2. Singh BN, Lilleberg J, Sandell EP, Ylönen V, Lehtonen L, Toivonen L. Effects of levosimendan on cardiac arrhythmia: electrophysiologic and ambulatory electrocardiographic findings in phase II and phase III clinical studies in cardiac failure. Am J Cardiol 1999;83(Suppl 2)16-20
  3. Haikala H, Linden IB. Mechanisms of action of calcium- sensitizing drugs. J Cardiovasc Pharmacol 1995;26:10-9
  4. Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation 1998;98:2141-7
  5. Fotbolcu H, Duman D. A promising new inotrope: levosimendan. Anadolu Kardiyol Derg 2010;10:176-82
  6. Dursun A, Topaloğlu S, Korkmaz Ş. A new inotropic agent in the treatment of decompensated heart failure: Levosimendan. Arch Turk Soc Cardiol 2007;35:48-56
  7. Alvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodríguez J, et al. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 2006;59:338-45. [Abstract] 8. Kayaalp O. Respect to Rational Therapy Medical Pharmacology. Ankara: Hacettepe-Taş Publisher; 2002
  8. García-González MJ, Domínguez-Rodríguez A, Ferrer- Hita JJ, Abreu-González P, Muñoz MB. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics. Eur J Heart Fail 2006;8:723-8
  9. Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol 2001;81:141-9
  10. Attaran S, John L, El-Gamel A. Clinical and potential use of pharmacological agents to reduce radial artery spasm in coronary artery surgery. Ann Thorac Surg 2008;85:1483-9
  11. Conant AR, Shackcloth MJ, Oo AY, Chester MR, Simpson AW, Dihmis WC. Phenoxybenzamine treatment is insufficient to prevent spasm in the radial artery: the effect of other vasodilators. J Thorac Cardiovasc Surg 2003;126:448-54
  12. Coonar AS, Pepper JR. Vasodilator pre-treatment of human radial arteries. Eur Heart J 2001;22:2146-7
  13. Sarabu MR, McClung JA, Fass A, Reed GE. Early postoperative spasm in left internal mammary artery bypass grafts. Ann Thorac S